Company / Current Liabilities
KYNTRA BIO, INC. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$29.2M
FY2025
5-year range
$29.2M / $273.6M
FY2021-FY2025
Trend
-78.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has declined for 3 consecutive years, from $274M in FY2022 to $29M in FY2025.
Based on SEC 10-K filings.
$29M in FY2025 with a 5-year CAGR of -29.1%.
Improved from $218M to $29M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -52.5%
- 5-Year CAGR
- -29.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- KYNTRA BIO, INC.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -29.1%, indicating a declining trend.
- In FY2025, current liabilities decreased 78.1% year-over-year.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.2M | -78.1% |
| FY2024 | $133.3M | -38.8% |
| FY2023 | $217.7M | -20.4% |
| FY2022 | $273.6M | +67.6% |
| FY2021 | $163.2M | +0.0% |
| FY2020 | $163.2M | +58.8% |
| FY2019 | $102.7M | +15.4% |
| FY2018 | $89.0M | +15.2% |
| FY2017 | $77.3M | +18.6% |
| FY2016 | $65.1M | -3.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026